Drug Type Small molecule drug |
Synonyms Lomerazine, Lomerizine, Lomerizine hydrochloride (JAN) + [6] |
Target |
Action inhibitors |
Mechanism calcium channel inhibitors(Calcium Channel inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (12 Mar 1999), |
Regulation- |
Molecular FormulaC27H32Cl2F2N2O3 |
InChIKeyLOGVKVSFYBBUAJ-UHFFFAOYSA-N |
CAS Registry101477-54-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02633 | Lomerizine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Migraine Disorders | Japan | 12 Mar 1999 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 2 | Japan | - | 24 Aug 2003 |
Brain Infarction | Phase 2 | Japan | - | - |
Not Applicable | 120 | giqvghpprx(zzvdrlzqcj) = rtsphuxepv jtbgkwwznr (tfvqdotrof ) | Positive | 01 Apr 2014 | |||
giqvghpprx(zzvdrlzqcj) = awruoezjyt jtbgkwwznr (tfvqdotrof ) | |||||||
Not Applicable | - | Vehicle-treated group | jtrssbdrrk(jvkcyumnzf) = trsrqjwkbz agfuijpbwd (vcxnxkgist ) | Positive | 01 May 2003 | ||
jtrssbdrrk(jvkcyumnzf) = rxesgygzjz agfuijpbwd (vcxnxkgist ) |